ZF
TEVA icon

Zhang Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Zhang Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Buy
12,200
+2,200
+22% +$70.8K 0.01% 284
2025
Q4 		$312K Sell
10,000
-6,700
-40% -$165K 0.01% 267
2025
Q3 		$337K Sell
16,700
-600
-3% -$10.5K 0.01% 251
2025
Q2 		$290K Buy
17,300
+100
+0.6% +$1.61K 0.01% 250
2025
Q1 		$264K Buy
17,200
+2,000
+13% +$35.7K 0.01% 258
2024
Q4 		$335K Sell
15,200
-900
-6% -$16.4K 0.02% 230
2024
Q3 		$290K Sell
16,100
-2,900
-15% -$50.8K 0.02% 230
2024
Q2 		$309K Sell
19,000
-7,000
-27% -$108K 0.02% 221
2024
Q1 		$367K Hold
26,000
– – 0.03% 209
2023
Q4 		$271K Hold
26,000
– – 0.02% 226
2023
Q3 		$265K Buy
26,000
+3,150
+14% +$29.3K 0.03% 207
2023
Q2 		$172K Buy
22,850
+1,900
+9% +$15.4K 0.02% 241
2023
Q1 		$185K Hold
20,950
– – 0.02% 225
2022
Q4 		$191K Sell
20,950
-1,000
-5% -$8.73K 0.02% 222
2022
Q3 		$177K Buy
21,950
+950
+5% +$8.4K 0.03% 209
2022
Q2 		$158K Hold
21,000
– – 0.03% 210
2022
Q1 		$197K Buy
21,000
+500
+2% +$4.17K 0.03% 211
2021
Q4 		$164K Buy
20,500
+3,200
+18% +$28.9K 0.03% 201
2021
Q3 		$169K Buy
17,300
+2,300
+15% +$21.5K 0.04% 159
2021
Q2 		$149K Buy
15,000
+1,500
+11% +$15.9K 0.04% 143
2021
Q1 		$156K Buy
+13,500
New +$155K 0.04% 128

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zhang Financial's TEVA Position: Q1 2026 in Review

Zhang Financial increased its Teva Pharmaceuticals (TEVA) stake by 22% in Q1 2026, buying an estimated $70.8K and bringing the position to 12,200 shares worth $367K. The position accounts for 0.01% of the portfolio, ranked #284.

Zhang Financial first reported a position in TEVA in Q1 2021 and has held it in 21 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Zhang Financial held 12,200 shares of Teva Pharmaceuticals worth $367K as of Q1 2026.
  • Zhang Financial bought 2,200 Teva Pharmaceuticals shares in Q1 2026, an estimated $70.8K.
  • Teva Pharmaceuticals made up 0.01% of Zhang Financial's portfolio in Q1 2026, its #284 holding.
  • Zhang Financial first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Zhang Financial's 13F filing for Q1 2026, filed 6 May 2026.